» Authors » Sunjay Kaushal

Sunjay Kaushal

Explore the profile of Sunjay Kaushal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 101
Citations 1124
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Kaushal S, Hare J, Hoffman J, Boyd R, Ramdas K, Pietris N, et al.
Eur Heart J Open . 2023 Mar; 3(2):oead002. PMID: 36950450
Aims: Hypoplastic left heart syndrome (HLHS) survival relies on surgical reconstruction of the right ventricle (RV) to provide systemic circulation. This substantially increases the RV load, wall stress, maladaptive remodelling,...
12.
Mishra R, Saha P, Datla S, Mellacheruvu P, Gunasekaran M, Guru S, et al.
J Transl Med . 2023 Mar; 21(1):168. PMID: 36869398
No abstract available.
13.
Baumgardt S, Fang J, Fu X, Liu Y, Xia Z, Zhao M, et al.
bioRxiv . 2023 Mar; PMID: 36865233
Background: Diabetes augments activity of histone deacetylase 6 (HDAC6) and generation of tumor necrosis factor α (TNFα) and impairs the physiological function of mitochondrial complex I (mCI) which oxidizes reduced...
14.
Fu X, Mishra R, Chen L, Arfat M, Sharma S, Kingsbury T, et al.
iScience . 2023 Feb; 26(2):105963. PMID: 36818289
Cardiac fibrosis is a hallmark in late-stage familial dilated cardiomyopathy (DCM) patients, although the underlying mechanism remains elusive. Cardiac exosomes (Exos) have been reported relating to fibrosis in ischemic cardiomyopathy....
15.
de Miguel-Perez D, Russo A, Gunasekaran M, Buemi F, Hester L, Fan X, et al.
Cancer . 2022 Dec; 129(4):521-530. PMID: 36484171
Background: Immune-checkpoint inhibitors (ICIs) are an effective therapeutic strategy, improving the survival of patients with lung cancer compared with conventional treatments. However, novel predictive biomarkers are needed to stratify which...
16.
Mehta V, Bilewska A, Kaushal S
Ann Thorac Surg . 2022 Sep; 116(6):1345-1346. PMID: 36108709
No abstract available.
17.
Devlin P, Kaushal S
J Thorac Cardiovasc Surg . 2022 Aug; 165(4):1517-1518. PMID: 35963798
No abstract available.
18.
Mishra R, Saha P, Datla S, Mellacheruvu P, Gunasekaran M, Guru S, et al.
J Transl Med . 2022 Jul; 20(1):323. PMID: 35864544
Background: Despite promising results in clinical studies, the mechanism for the beneficial effects of allogenic cell-based therapies remains unclear. Macrophages are not only critical mediators of inflammation but also critical...
19.
Gunasekaran M, Mishra R, Saha P, Morales D, Cheng W, Jayaraman A, et al.
iScience . 2022 Jul; 25(8):104656. PMID: 35847554
Successful cell therapy requires cells to resist the hostile ischemic myocardium, be retained to continue secreting cardioprotective growth factors/exosomes, and resist immunological host responses. Clinically relevant stem/progenitor cells in a...
20.
Cao S, Wu Y, Reece E, Xu C, Shen W, Kaushal S, et al.
Commun Biol . 2022 Jul; 5(1):648. PMID: 35778435
Various types of progenitors initiate individual organ formation and their crosstalk orchestrates morphogenesis for the entire embryo. Here we show that progenitor exosomal communication across embryonic organs occurs in normal...